These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 8513368)
1. A dose of pharmaco-economics. Can health networks learn from the drug policies of managed care plans? Taylor KS; Hagland MM Hosp Health Netw; 1993 Jul; 67(13):33-6. PubMed ID: 8513368 [No Abstract] [Full Text] [Related]
2. Wholesaling in the managed care market. Toscano S Med Interface; 1995 Dec; 8(12):78-81. PubMed ID: 10153522 [No Abstract] [Full Text] [Related]
3. Employers push to manage prescription drug costs. Frieden J Bus Health; 1992 May; 10(6):43-6, 48, 50. PubMed ID: 10119119 [No Abstract] [Full Text] [Related]
4. Precipitating factors for pharmaceutical firms. McCarthy R State Health Care Am; 1997; ():39-43. PubMed ID: 10168083 [No Abstract] [Full Text] [Related]
5. Managed care cost containment involving prescription drugs. American Medical Association, Council on Ethical and Judicial Affairs. Food Drug Law J; 1998; 53(1):25-34. PubMed ID: 11795334 [No Abstract] [Full Text] [Related]
6. Pharmaceuticals issue brief: managed care drug formularies: year end report-2003. MacEachern L Issue Brief Health Policy Track Serv; 2003 Dec; ():1-8. PubMed ID: 14969259 [TBL] [Abstract][Full Text] [Related]
7. Questions and answers about managed competition. Clancy CM; Himmelstein DU; Woolhandler S Health PAC Bull; 1993; 23(1):30-2. PubMed ID: 10126177 [No Abstract] [Full Text] [Related]
8. The effect of drug reimportation on managed care pharmacy. Penna P Manag Care Interface; 2003 Jul; 16(7):41-2. PubMed ID: 12908216 [No Abstract] [Full Text] [Related]
9. Controlling the cost of branded drugs. Mandelker J Bus Health; 1993 Nov; 11(13):44-6, 48. PubMed ID: 10130506 [TBL] [Abstract][Full Text] [Related]
10. Prescription drug benefits: Rx for cost management--commentary. Carlsen MA Benefits Q; 1993; 9(3):81-8. PubMed ID: 10127207 [No Abstract] [Full Text] [Related]
11. Specialty pharmacy management adjusts to new financial realities. Reinke T Manag Care; 2013 Apr; 22(4):13-4. PubMed ID: 23678558 [No Abstract] [Full Text] [Related]
12. Testimony on managed competition. The effects of cost control provisions on health expenditures. Reischauer RD Caring; 1993 Jun; 12(6):18, 20, 23-8. PubMed ID: 10125988 [No Abstract] [Full Text] [Related]
13. Testimony on managed competition. The Jackson Hole approach. Achieving effective cost control in comprehensive health care reform. Enthoven A Caring; 1993 Jun; 12(6):16-8. PubMed ID: 10125987 [No Abstract] [Full Text] [Related]
14. Controlling costs by "managed competition"--would it work? Relman AS N Engl J Med; 1993 Jan; 328(2):133-5. PubMed ID: 8257459 [No Abstract] [Full Text] [Related]
15. Managing drug costs: the perception of managed care pharmacy directors. Litton LM; Sisk FA; Akins ME Am J Manag Care; 2000 Jul; 6(7):805-14. PubMed ID: 11067377 [TBL] [Abstract][Full Text] [Related]
16. Plans struggle for control of specialty pharma costs. Carroll J Manag Care; 2005 Sep; 14(9):41-2, 45-8. PubMed ID: 16238258 [No Abstract] [Full Text] [Related]
17. Cut pharmaceutical costs, but mind the legal dangers. Abood RR Manag Care; 1997 Aug; 6(8):47-8, 51-4. PubMed ID: 10170246 [No Abstract] [Full Text] [Related]
19. Health care reform. Six questions for President Clinton. Wiener JM; Illston LH Brookings Rev; 1993; 11(2):22-5. PubMed ID: 10124884 [No Abstract] [Full Text] [Related]
20. Marketplace. Managed care plans try to cope as drug ads spur patient demand. Moskowitz DB Med Health; 1998 May; 52(20):suppl 1-2. PubMed ID: 10179010 [No Abstract] [Full Text] [Related] [Next] [New Search]